How our Center for Rare Melanomas is helping to advance the field of rare melanoma research, and share this knowledge with the world.
Below are publications involving rare melanoma research from either our own scientists and collaborators at the Center for Rare Melanomas, or as the result of sharing our Biorepository specimens and models:
We share the most recent advances in our rare melanoma research through invited presentations at local, national and international conferences:
We strive to build upon previous and current support to bring in new funding (peer-reviewed, private, and industry-sponsored) to continue exploring and making novel discoveries in the rare melanoma field:
Sponsor | PI | Title | Period |
The Patten-Davis Foundation | William A. Robinson, Kasey L. Couts, Ph.D. (Co-I) | CU Center for Rare Melanomas | 07/01/2019-07/01/2022 |
The Moore Family Foundation | William A. Robinson | Melanoma Biorepository. | 07/01/2014-Present |
Genentech, Inc. | Kasey L. Couts, Ph.D. | Treating melanomas with a novel pan-RAF inhibitor. | November 2018-Present |
Foundation Medicine, Inc. | Kasey L. Couts, Ph.D. | Comprehensive genomic profiling of acral and mucosal melanomas. | January 2016-Present |
Ignyta, Inc. | Kasey L. Couts, Ph.D. | Targeted gene fusion sequencing in acral and mucosal melanomas. | January 2016-Present |
American Cancer Society-Institutional Seed Grant | Kasey L. Couts, Ph.D. | Targeting cell cycle structural variants in acral and mucosal melanomas. | 1/1/2018 – 12/31/2018 |
Cancer League of Colorado Grant | Kasey L. Couts, Ph.D. | Improving targeted therapy in melanomas with BRAF fusions. | 7/1/2017 – 06/30/2018 |
American Cancer Society, Paul R. Ohara II Seed Grant Program | Kasey L. Couts, Ph.D. | Gene fusions as actionable therapeutic targets in acral and mucosal melanomas. | 1/1/2016 – 06/30/2017 |
Colorado Clinical and Translational Sciences Institute Grant | Kasey L. Couts, Ph.D. | Activating gene fusions as targets in malignant melanoma. | 3/5/2016 – 03/04/2017 |
NuGEN, Inc. | Kasey L. Couts, Ph.D. | Targeted sequencing of gene fusions across melanoma subtypes. | Nov. 2015 – Dec. 2017 |
RNA Biosciences Initiative – CU Anschutz | Kelsey Weunsch Nassar, BA | Determining the role of SF3B1 mutations in mucosal melanoma | 09/01/2019 – 08/31/2020 |
NIH/NCI T32CA190216 | Kelsey Weunsch Nassar, BA | Determining the role of SF3B1 mutations in mucosal melanoma | 08/01/2017 – 07/31/2019 |
CU Anschutz
Anschutz Cancer Pavilion
1665 North Aurora Court
3rd Floor
Aurora, CO 80045
Clinic: 720-848-0505 Laboratory: 303-724-1473